Thomas J. Schuetz
Insider (Form 4 reporting owner): CHIEF EXECUTIVE OFFICER CIK 1591464Name as filed: Schuetz Thomas J.Its filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 19 Jun 2020, bought $1.7M in 23 open-market purchases of Compass Therapeutics.
Companies
Role on the latest Form 4 for each; open-market trades counted| Company | Role | Trades from | to | Purchases | Sales |
|---|---|---|---|---|---|
| Compass Therapeutics CMPX | CHIEF EXECUTIVE OFFICER | 19 Jun 2020 | 27 May 2025 | 23$1.7M | – |
What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After purchases | -1.3 pts9 trades, 44% above the sector | +23.3 pts9 trades, 56% above the sector | -3.9 pts9 trades, 44% above the sector |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2025 | 1 | $21K | – | – | $21K |
| 2023 | 5 | $355K | – | – | $355K |
| 2022 | 16 | $797K | – | – | $797K |
| 2020 | 1 | $487K | – | – | $487K |
Every trade
23, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 27 May 2025 | Compass Therapeutics CMPX | Buy | 10,000 | $2.11 | $21K | No | Form 4filed 27 May 2025 |
| 10 Mar 2023 | Compass Therapeutics CMPX | Buy | 10,000 | $3.37 | $34K | Not stated | Form 4filed 10 Mar 2023 |
| 27 Feb 2023 | Compass Therapeutics CMPX | Buy | 20,000 | $3.98 | $80K | Not stated | Form 4filed 27 Feb 2023 |
| 15 Feb 2023 | Compass Therapeutics CMPX | Buy | 20,000 | $3.86 | $77K | Not stated | Form 4filed 15 Feb 2023 |
| 31 Jan 2023 | Compass Therapeutics CMPX | Buy | 20,000 | $4.05 | $81K | Not stated | Form 4filed 31 Jan 2023 |
| 24 Jan 2023 | Compass Therapeutics CMPX | Buy | 20,000 | $4.19 | $84K | Not stated | Form 4filed 24 Jan 2023 |
| 28 Sep 2022 | Compass Therapeutics CMPX | Buy | 10,000 | $2.32 | $23K | Not stated | Form 4filed 28 Sep 2022 |
| 26 Sep 2022 | Compass Therapeutics CMPX | Buy | 15,000 | $2.27 | $34K | Not stated | Form 4filed 27 Sep 2022 |
| 7 Sep 2022 | Compass Therapeutics CMPX | Buy | 15,000 | $3.03 | $45K | Not stated | Form 4filed 8 Sep 2022 |
| 1 Sep 2022 | Compass Therapeutics CMPX | Buy | 15,000 | $2.83 | $42K | Not stated | Form 4filed 1 Sep 2022 |
| 17 Aug 2022 | Compass Therapeutics CMPX | Buy | 15,000 | $3.05 | $46K | Not stated | Form 4filed 17 Aug 2022 |
| 10 Aug 2022 | Compass Therapeutics CMPX | Buy | 15,000 | $2.64 | $40K | Not stated | Form 4filed 10 Aug 2022 |
| 1 Aug 2022 | Compass Therapeutics CMPX | Buy | 15,000 | $2.58 | $39K | Not stated | Form 4filed 2 Aug 2022 |
| 21 Jun 2022 | Compass Therapeutics CMPX | Buy | 20,000 | $2.80 | $56K | Not stated | Form 4filed 21 Jun 2022 |
| 16 Jun 2022 | Compass Therapeutics CMPX | Buy | 20,000 | $2.34 | $47K | Not stated | Form 4filed 17 Jun 2022 |
| 13 Jun 2022 | Compass Therapeutics CMPX | Buy | 30,000 | $2.29 | $69K | Not stated | Form 4filed 13 Jun 2022 |
| 6 Jun 2022 | Compass Therapeutics CMPX | Buy | 30,000 | $2.83 | $85K | Not stated | Form 4filed 7 Jun 2022 |
| 1 Jun 2022 | Compass Therapeutics CMPX | Buy | 20,000 | $3.03 | $61K | Not stated | Form 4filed 1 Jun 2022 |
| 26 May 2022 | Compass Therapeutics CMPX | Buy | 20,000 | $3.04 | $61K | Not stated | Form 4filed 26 May 2022 |
| 23 May 2022 | Compass Therapeutics CMPX | Buy | 18,355 | $2.72 | $50K | Not stated | Form 4filed 24 May 2022 |
| 17 May 2022 | Compass Therapeutics CMPX | Buy | 20,215 | $2.47 | $50K | Not stated | Form 4filed 17 May 2022 |
| 10 May 2022 | Compass Therapeutics CMPX | Buy | 27,836 | $1.80 | $50K | Not stated | Form 4filed 10 May 2022 |
| 19 Jun 2020 | Compass Therapeutics CMPX | Buy | 97,431 | $5.00 | $487K | Not stated | Form 4filed 23 Jun 2020 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.